Aspergillosis

AB1_ASPERGILLOSIS

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 B44
  • Hospital discharge: ICD-9 1173
  • Hospital discharge: ICD-8 1173
  • Cause of death: ICD-10 B44
  • Cause of death: ICD-9 1173
  • Cause of death: ICD-8 1173

2 out of 7 registries used, show all original rules.

307

4. Check minimum number of events

None

307

5. Include endpoints

None

307

6. Filter based on genotype QC (FinnGen only)

295

Control definitions (FinnGen only)

Control exclude
AB1_MYCOSES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1897 694 1166
Only index persons 1320 508 812
Unadjusted period prevalence (%)
Whole population 0.03 0.02 0.03
Only index persons 0.03 0.02 0.03
Median age at first event (years)
Whole population 62.18 61.22 62.71
Only index persons 62.61 60.94 63.65

-FinnGen-

Key figures

All Female Male
Number of individuals 295 112 183
Unadjusted period prevalence (%) 0.07 0.04 0.08
Median age at first event (years) 63.87 59.03 66.84

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
307
Matched controls
3070
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
+∞
161.0
140
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
18.5
139.2
140
133
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
22.7
138.3
117
81
J02AC03
ATC
voriconazole; systemic
654.7
129.2
119
*
TGC00
NOMESCO Finland
Bronchial lavation
25.7
121.7
93
51
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
11.7
96.9
131
184
J01MA14
ATC
moxifloxacin; systemic
10.5
82.1
115
166
J18.9
ICD-10 Finland
Pneumonia, unspecified
8.7
80.1
202
555
R03BB04
ATC
tiotropium bromide; inhalant
9.3
75.9
120
199
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
+∞
75.1
69
*
J47
ICD-10 Finland
Bronchiectasis
23.7
72.9
55
28
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
11.9
72.0
84
94
GD1AD
NOMESCO Finland
Thorax CT examination
11.4
69.8
84
98
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
15.6
68.8
65
52
B44.9
ICD-10 Finland
Aspergillosis, unspecified
+∞
64.9
60
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
9.0
64.8
98
152
R04.2
ICD-10 Finland
Haemoptysis
17.3
63.8
56
39
B44.8
ICD-10 Finland
Other forms of aspergillosis
738.9
63.2
60
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
16.4
63.0
57
42
J45.0
ICD-10 Finland
Predominantly allergic asthma
8.1
52.4
84
137
J01MA12
ATC
levofloxacin; systemic
5.8
51.5
144
404
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
5.8
50.6
139
383
GD1AA
NOMESCO Finland
Thorax X-ray examination
6.2
45.6
238
1092
R03AK08
ATC
formoterol and beclometasone; inhalant
11.1
44.6
51
54
J45.9
ICD-10 Finland
Asthma, unspecified
5.3
43.4
123
342
H02AB06
ATC
prednisolone; systemic
5.7
42.5
233
1088
J45.1
ICD-10 Finland
Nonallergic asthma
7.4
41.7
69
115
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.2
41.6
118
327
R03AK06
ATC
salmeterol and fluticasone; inhalant
5.1
38.7
108
293
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
7.5
38.5
62
100
XG410
NOMESCO Finland
Flow-volume spirometry
9.1
37.7
50
64
H62.2*B44.8
ICD-10 Finland
Otitis externa in aspergillosis
+∞
37.2
35
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
7.8
37.1
57
87
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.1
36.8
49
63
R03DC03
ATC
montelukast; oral
5.1
36.2
100
268
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.9
34.0
72
152
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.1
33.8
57
96
H02AB04
ATC
methylprednisolone; systemic
4.8
33.2
97
270
L03AA02
ATC
filgrastim; parenteral
10.1
33.2
40
45
R03AC12
ATC
salmeterol; inhalant
7.2
30.7
50
81
R81
ICPC
Pneumonia
9.0
29.7
39
49
127
Kela drug reimbursment
Transplant complication
30.7
28.8
38
14
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.4
28.1
51
92
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
5.7
27.8
59
124
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.5
27.3
81
225
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.9
27.1
215
1157
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.1
25.7
33
40
R50.9
ICD-10 Finland
Fever, unspecified
4.1
25.7
89
277
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.3
24.9
80
235
XW000
NOMESCO Finland
Bone marrow biopsy
6.8
24.9
42
70
H02AB07
ATC
prednisone; oral
4.2
24.0
79
236
R03AC13
ATC
formoterol; inhalant
6.3
23.3
42
75
J02AC05
ATC
isavuconazole; systemic
+∞
23.2
22
*
J45.8
ICD-10 Finland
Mixed asthma
9.3
23.1
29
34
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
4.2
23.1
73
211
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
8.5
23.0
31
40
R03BA01
ATC
beclometasone; inhalant
4.0
22.2
75
227
R03DA04
ATC
theophylline; systemic, rectal
5.5
22.1
47
98
J02AC04
ATC
posaconazole; systemic
236.1
21.9
22
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.8
21.7
43
84
R03BA05
ATC
fluticasone; inhalant
3.5
21.2
93
336
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
82.7
21.0
23
*
JN4BD
NOMESCO Finland
Extensive body CT
4.0
20.0
68
206
H02AB09
ATC
hydrocortisone; systemic
8.4
19.9
27
35
WX892
NOMESCO Finland
Monitored bed care
4.8
19.9
49
116
R03AC02
ATC
salbutamol; inhalant
3.2
19.8
209
1239
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
9.0
19.5
25
30
J01FA06
ATC
roxithromycin; oral
3.0
19.5
167
882
A07AA02
ATC
nystatin; oral
5.8
19.0
37
71
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
5.3
18.8
41
87
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.6
18.8
49
121
TDM10
NOMESCO Finland
Puncture of maxillary antrum
6.5
18.6
32
54
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.9
18.6
140
685
WW500
NOMESCO Finland
Blood transfusion
5.9
18.2
35
66
GDC00
NOMESCO Finland
Lobectomy of lung
56.1
18.2
21
*
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
6.7
18.0
30
49
J17.2*B44.1
ICD-10 Finland
Pneumonia in other aspergillosis
+∞
17.9
17
*
L04AA06
ATC
mycophenolic acid; systemic
17.0
17.9
28
18
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
17.7
113
503
L04AD02
ATC
tacrolimus; systemic
30.9
17.7
23
8
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
7.6
17.7
26
37
R03AK11
ATC
formoterol and fluticasone; inhalant
7.9
17.6
25
34
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
17.6
105
450
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.4
17.3
47
120
J17.2*B44.0
ICD-10 Finland
Pneumonia in invasive aspergillosis
+∞
16.8
16
*
49300
ICD-8 Finland
Asthma, bronchiale
7.5
16.8
25
36
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
4.7
16.5
41
97
J45
ICD-10 Finland
Asthma
4.0
16.5
53
153
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.7
16.5
32
61
JN4CD
NOMESCO Finland
Very extensive body CT
6.0
16.4
30
54
Z2446
NOMESCO Finland
Social worker
4.7
16.3
40
94
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.1
16.2
89
362
R03AK07
ATC
formoterol and budesonide; inhalant
3.0
16.0
89
364
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
28.0
15.8
21
8
J01FA15
ATC
telithromycin; oral
3.9
15.6
52
154
J46
ICD-10 Finland
Status asthmaticus
12.8
15.4
27
23
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
33.6
15.0
19
6
J01FF01
ATC
clindamycin; systemic
2.7
14.8
112
537
ZX120
NOMESCO Finland
Intravenous
3.6
14.6
55
177
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
14.4
14.5
24
18
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
4.8
14.4
34
77
J02AC02
ATC
itraconazole; systemic
3.1
14.4
75
294
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.8
14.4
91
397
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
14.2
84
353
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
7.1
14.2
22
33
L04AD01
ATC
ciclosporin; systemic
13.6
14.2
24
19
J01MA02
ATC
ciprofloxacin; systemic
2.5
13.9
156
897
XG474
NOMESCO Finland
Exhalation nntrogen oxide
6.6
13.9
23
37
WW200
NOMESCO Finland
Immunization
10.8
13.8
26
26
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.3
13.7
24
41
JN4AD
NOMESCO Finland
Body CT examination
3.4
13.5
56
191
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
5.8
13.3
25
46
J01FA09
ATC
clarithromycin; systemic
2.5
13.2
119
615
R03BA08
ATC
ciclesonide; inhalant
3.7
13.2
45
135
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
20.2
13.1
19
10
A02BC02
ATC
pantoprazole; systemic
2.8
13.1
235
1664
J01FA10
ATC
azithromycin; systemic
2.5
12.8
192
1244
A04AA01
ATC
ondansetron; systemic, rectal
3.7
12.7
44
133
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
6.6
12.6
21
34
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
12.6
57
205
J01AA02
ATC
doxycycline; systemic
3.1
12.4
259
1951
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
12.3
81
358
R03BA02
ATC
budesonide; inhalant
2.7
12.3
79
345
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
12.2
115
604
Z94.2
ICD-10 Finland
Lung transplant status
48.7
12.0
14
*
ZXD05
NOMESCO Finland
Urgent procedure
2.4
11.9
112
587
M05BA04
ATC
alendronic acid; oral
3.7
11.8
41
124
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
17.3
11.8
18
11
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
11.8
89
420
R4110
NOMESCO Finland
Physiotherapy
2.4
11.5
108
564
XF400
NOMESCO Finland
ECG with 12 standard connections
2.7
11.2
73
320
C03CA01
ATC
furosemide; systemic
2.3
11.1
123
688
J96.1
ICD-10 Finland
Chronic respiratory failure
8.8
11.0
23
28
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
4.1
11.0
31
81
R03AK03
ATC
[U] fenoterol and ipratropium bromide
3.8
10.9
36
105
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.4
10.9
28
68
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
5.9
10.8
20
36
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
62.2
10.7
12
*
R06.0
ICD-10 Finland
Dyspnoea
2.3
10.6
106
565
B44.7
ICD-10 Finland
Disseminated aspergillosis
+∞
10.5
10
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.6
10.2
35
105
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
10.0
69
310
R4190
NOMESCO Finland
Nutritional therapy
5.2
9.9
21
43
J05AB11
ATC
valaciclovir; oral
2.7
9.9
63
271
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.8
9.9
32
92
R03BB01
ATC
ipratropium bromide; inhalant
4.3
9.9
26
64
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.7
9.9
33
97
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
4.6
9.8
24
56
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.4
9.7
78
375
GDG10
NOMESCO Finland
Bilateral transplantation of lung
56.8
9.7
11
*
SPAT1255
SPAT
Intravenous administration of medicine
3.7
9.6
32
94
Z3226
NOMESCO Finland
Physiotherapist
2.5
9.5
72
337
J33.0
ICD-10 Finland
Polyp of nasal cavity
5.4
9.5
19
37
ZX112
NOMESCO Finland
Subcutaneous
5.4
9.5
19
37
J01GB01
ATC
tobramycin; inhalant, parenteral
103.1
9.5
10
*
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
103.1
9.5
10
*
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
103.1
9.5
10
*
H60.9
ICD-10 Finland
Otitis externa, unspecified
3.3
9.5
37
121
A05AA02
ATC
ursodeoxycholic acid; oral
10.0
9.4
18
19
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
7.7
9.4
21
29
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
12.0
9.2
16
14
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
19.3
9.0
13
7
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
13.1
9.0
15
12
J02AC01
ATC
fluconazole; systemic
2.1
8.9
115
672
R03AC03
ATC
terbutaline; inhalant
2.7
8.9
53
220
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
4.4
8.9
23
56
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
7.0
8.8
21
32
ZX108
NOMESCO Finland
Inhalation
14.6
8.8
14
10
J85.2
ICD-10 Finland
Abscess of lung without pneumonia
51.5
8.7
10
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
4.8
8.7
20
44
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
20.7
8.5
12
6
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.2
8.5
98
546
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
13.3
8.5
14
11
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
9.9
8.4
16
17
GDB10
NOMESCO Finland
Wedge resection of lung
+∞
8.4
8
*
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
+∞
8.4
8
*
A41.9
ICD-10 Finland
Sepsis, unspecified
4.4
8.3
21
50
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.6
8.3
20
46
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
15.0
8.3
13
9
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
8.2
78
401
Z2221
NOMESCO Finland
Medical doctor
2.2
8.2
93
514
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.8
8.2
44
173
RS220, ,
NOMESCO Finland
17.8
8.1
12
7
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
34.3
8.1
10
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
34.3
8.1
10
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
8.1
41
156
WX872
NOMESCO Finland
Intensive care
3.5
8.0
28
85
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.0
7.9
136
875
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.2
7.9
32
107
R01AD08
ATC
fluticasone; nasal
2.1
7.8
97
554
A03
ICPC
Fever
2.4
7.8
58
268
AA1AD
NOMESCO Finland
CT of head and brain
2.1
7.8
98
563
5BA08, ,
NOMESCO Finland
46.2
7.8
9
*
R06.2
ICD-10 Finland
Wheezing
4.2
7.7
21
53
N02AA05
ATC
oxycodone; systemic
2.3
7.7
72
367
ZXE40
NOMESCO Finland
More than seven and less than nine hours
7.0
7.7
18
27
UDM02
NOMESCO Finland
Sinoscopy
6.5
7.7
19
31
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
18.9
7.7
11
6
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
25.7
7.6
10
*
J01DB01
ATC
cefalexin; oral
2.4
7.5
260
2133
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
3.8
7.5
23
64
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.8
7.5
23
64
R06AE07
ATC
cetirizine; oral
2.0
7.4
130
839
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
9.7
7.4
14
15
A10AC01
ATC
insulin (human); parenteral
2.9
7.3
35
129
WX002
NOMESCO Finland
Sedation and analgesia
2.2
7.3
72
375
R01AD09
ATC
mometasone; nasal
1.9
7.3
141
938
J98.1
ICD-10 Finland
Pulmonary collapse
20.6
7.2
10
5
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
12.4
7.1
12
10
R03DC01
ATC
zafirlukast; oral
7.3
7.1
16
23
N03AX16
ATC
[U] pregabalin
2.1
7.1
82
455
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
5.7
7.0
19
35
N02AX02
ATC
tramadol; systemic, rectal
1.9
7.0
145
983
J01CA04
ATC
amoxicillin; systemic
2.2
7.0
252
2060
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
6.9
46
201
J43.9
ICD-10 Finland
Emphysema, unspecified
6.4
6.9
17
28
J96.0
ICD-10 Finland
Acute respiratory failure
11.3
6.9
12
11
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
9.6
6.9
13
14
A02BC01
ATC
omeprazole; systemic
2.0
6.8
92
538
H60.8
ICD-10 Finland
Other otitis externa
4.1
6.8
19
49
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
17.2
6.8
10
6
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
17.2
6.8
10
6
L01BB05
ATC
fludarabine; systemic
41.0
6.8
8
*
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
23.1
6.7
9
*
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
23.1
6.7
9
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
12.6
6.6
11
9
J32.4
ICD-10 Finland
Chronic pansinusitis
9.0
6.6
13
15
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.3
6.6
25
80
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
4.1
6.5
18
46
J01DA01
ATC
[U] cefalexin
1.9
6.5
193
1456
WX600
NOMESCO Finland
Single shot through catheter
14.7
6.4
10
7
R02
ICPC
Shortness of breath/dyspnoea
2.4
6.4
46
208
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.4
6.4
23
71
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
8.4
6.4
13
16
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.1
6.3
27
93
D72.1
ICD-10 Finland
Eosinophilia
18.5
6.3
9
5
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.1
6.3
26
88
J17.2
ICD-10 Finland
Pneumonia in mycoses
+∞
6.3
6
*
A15.0
ICD-10 Finland
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
+∞
6.3
6
*
2AA01, ,
NOMESCO Finland
+∞
6.3
6
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
7.9
6.2
13
17
ZXE00
NOMESCO Finland
One hour or less
1.9
6.2
121
798
WZC30
NOMESCO Finland
Teaching
2.1
6.1
63
332
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.6
6.1
20
58
L03AA13
ATC
pegfilgrastim; parenteral
3.5
6.1
21
63
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
8.9
6.1
12
14
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
5.4
6.1
17
33

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
97
18
78.32
176.68
3.7
1.3
8.65
0.09
u/ml
5.56
84
13
114
45
39.71
171.67
6.6
2.5
—
—
—
0
0
182
313
12.82
117.35
5.2
1.4
—
—
—
0
0
98
7
204.45
98.86
3.0
1.6
—
—
—
0
0
111
139
11.94
88.84
4.6
1.2
1282.33
197.75
u/ml
2.48
106
125
112
199
8.29
65.79
4.7
2.2
9.52
10.77
g/l
1.83
101
181
53
46
13.72
53.03
5.5
2.7
—
—
—
0
0
139
398
5.55
48.06
12.4
3.4
0.80
0.83
mmol/l
2.32
134
375
132
380
5.34
44.91
3.6
2.0
—
—
—
0
0
37
26
16.04
41.48
1.4
1.2
2.67
2.65
g/l
0.02
20
21
37
26
16.04
41.48
1.4
1.2
0.38
0.35
g/l
0.20
21
21
112
298
5.34
41.42
2.8
1.5
—
—
—
0
0
36
28
14.43
38.08
1.4
1.2
—
—
—
0
0
42
43
11.16
37.38
1.5
1.9
0.69
0.99
g/l
0.45
26
35
77
162
6.01
36.70
2.6
1.5
1.22
1.37
g/l
0.19
70
146
172
736
4.04
32.50
10.5
4.4
—
—
—
0
0
231
1255
4.40
29.91
20.8
5.8
0.68
0.60
e9/l
5.14
220
1090
222
1174
4.22
29.87
24.4
6.6
—
—
—
0
0
231
1257
4.38
29.79
20.8
5.8
0.04
0.04
e9/l
1.23
221
1095
233
1297
4.30
28.55
23.2
6.1
0.22
0.20
e9/l
0.66
225
1150
30
28
11.77
28.20
2.9
2.5
—
—
—
0
0
231
1285
4.22
28.16
20.9
5.8
1.71
1.83
e9/l
0.88
222
1149
29
26
12.21
27.97
1.4
1.3
—
—
—
0
0
104
363
3.82
25.46
1.8
1.8
—
—
—
0
0
55
125
5.14
23.53
1.7
2.3
1.84
1.47
g/l
1.48
44
108
94
322
3.77
23.44
13.4
6.0
1.03
1.03
mmol/l
0.08
89
302
236
1450
3.71
22.14
31.3
10.0
4.66
4.14
e9/l
2.52
229
1281
73
224
3.96
21.17
10.4
4.2
0.92
0.89
%
0.04
48
98
199
1137
3.13
20.39
12.1
5.9
1.21
1.21
mmol/l
0.52
193
1033
32
51
6.89
19.69
2.1
1.4
—
—
—
0
0
66
198
3.97
19.66
9.4
4.3
0.60
0.52
%
0.17
42
78
30
46
7.12
19.11
2.1
1.4
101.38
98.40
u/ml
—
5
10
207
1238
3.06
19.00
16.8
6.9
1.20
1.21
mmol/l
0.98
186
1058
130
616
2.93
18.25
23.3
7.0
—
—
—
0
0
65
207
3.71
17.66
10.9
4.3
0.12
0.16
%
0.19
42
80
186
1080
2.83
17.50
10.9
5.0
32.49
35.29
g/l
7.51
181
1017
35
69
5.60
17.39
1.5
1.2
—
—
—
0
0
78
298
3.17
15.78
9.7
6.7
1.84
0.90
mmol/l
1.15
65
238
30
57
5.72
15.47
1.6
2.4
121.27
125.42
g/l
0.24
15
40
59
195
3.51
15.03
11.1
4.4
0.06
0.15
%
0.32
35
68
20
8
26.59
14.88
1.1
1.0
—
—
—
0
0
25
42
6.39
14.56
11.3
3.7
—
—
—
0
0
103
479
2.73
14.41
2.2
1.3
2.33
2.54
g/l
0.57
84
294
37
90
4.54
14.39
5.6
2.1
23.11
22.37
s
0.09
37
83
80
327
2.96
14.26
1.6
1.3
378.18
393.50
titre
0.04
22
80
58
196
3.42
14.24
2.1
1.4
—
—
—
0
0
19
8
25.19
13.96
1.3
1.3
—
—
—
0
0
123
636
2.56
13.77
2.6
2.0
3.50
3.25
mg/l
0.39
107
546
57
196
3.34
13.59
10.8
8.0
—
—
—
0
0
20
12
17.72
13.17
1.7
1.2
—
—
—
0
0
147
839
2.44
13.15
6.4
3.5
2.31
2.34
mmol/l
2.25
136
735
61
225
3.14
12.92
5.4
3.9
2.19
1.99
mmol/l
0.12
52
179
137
763
2.44
12.88
8.4
4.3
7.40
7.40
ph
0.16
25
147
52
176
3.35
12.67
4.4
4.3
—
—
—
0
0
193
1264
2.42
12.40
16.6
14.6
1.27
1.27
inr
0.01
52
363
16
6
28.00
12.17
4.4
4.3
—
—
—
0
0
25
50
5.35
12.16
1.4
1.1
305.46
299.31
u/ml
0.02
13
26
52
181
3.25
12.09
8.1
3.5
7.43
7.41
ph
—
10
16
247
1841
2.75
11.54
11.8
4.1
24.44
12.26
mm/h
10.91
237
1690
173
1103
2.30
11.52
28.8
9.7
0.00
0.00
e9/l
0.07
152
907
16
8
21.00
11.25
2.5
1.1
—
—
—
0
0
255
1943
2.84
11.18
27.4
8.2
86.90
79.91
u/l
1.41
250
1821
215
1518
2.39
11.04
10.7
4.5
6.53
6.72
mmol/l
0.77
206
1427
60
243
2.83
10.66
2.5
1.5
—
—
—
0
0
83
397
2.49
10.57
6.0
3.1
0.83
1.72
e6/l
1.30
60
226
47
168
3.12
10.41
1.5
1.5
—
—
—
0
0
121
688
2.25
10.34
6.1
3.2
0.42
0.45
e6/l
0.03
105
522
14
6
24.35
10.33
3.1
1.7
—
—
—
0
0
103
555
2.29
9.95
3.3
1.7
1.58
1.34
mg/l
0.27
88
446
19
20
10.05
9.91
1.2
1.2
—
—
—
0
0
130
774
2.18
9.80
6.3
3.2
58.45
150.23
e6/l
0.50
113
614
55
222
2.80
9.80
1.8
1.4
—
—
—
0
0
97
517
2.28
9.56
4.2
2.9
544.20
563.17
mosm/kgh2o
0.38
86
441
20
25
8.48
9.50
1.5
2.8
49.75
40.60
%
—
8
15
21
46
4.83
9.21
2.9
2.7
—
—
—
0
0
21
46
4.83
9.21
3.4
2.6
5.45
4.69
e9/l
0.46
21
46
27
74
3.90
8.94
8.2
3.4
—
—
—
0
0
21
48
4.62
8.76
3.4
3.0
59.86
59.71
%
0.02
21
48
114
672
2.11
8.59
5.9
3.1
—
—
—
0
0
97
538
2.17
8.54
3.9
2.5
3.46
4.02
e6/l
0.35
91
489
80
413
2.27
8.39
3.6
2.5
10.34
13.22
umol/l
3.08
74
384
55
243
2.54
8.14
5.1
2.8
59.77
70.43
e9/l
1.36
43
188
46
186
2.73
8.12
2.5
2.4
—
—
—
0
0
21
52
4.26
7.94
2.0
1.9
—
—
—
0
0
137
890
1.97
7.70
7.4
3.8
10.88
73.19
e6/l
4.06
117
655
212
1601
2.05
7.68
7.1
4.4
13.71
1946.26
e6/l
—
7
38
16
21
7.97
7.48
1.8
1.1
—
—
—
0
0
152
1033
1.93
7.40
4.1
2.6
415.11
152.17
ug/l
1.06
144
941
11
7
16.23
7.28
5.7
3.3
—
—
—
0
0
126
809
1.95
7.22
9.0
2.5
—
—
—
0
0
19
34
5.89
7.19
1.9
1.2
—
—
—
0
0
36
137
2.84
7.10
15.2
8.2
—
—
—
0
0
71
372
2.18
7.08
3.5
2.4
18.50
23.24
%
1.43
61
321
88
507
2.03
6.82
4.4
3.6
458.34
281.06
ng/l
0.49
74
405
10
6
17.15
6.79
1.1
1.0
—
—
—
0
0
107
668
1.92
6.54
8.1
2.9
339.27
6412.77
umol/l
2.68
97
586
60
303
2.22
6.52
1.8
1.6
—
—
—
0
0
71
384
2.10
6.49
3.5
2.4
2.14
2.30
g/l
1.73
66
355
19
52
3.83
6.30
4.4
3.0
—
—
—
0
0
6
0
+∞
6.27
2.7
0.0
—
—
—
0
0
55
273
2.24
6.22
1.9
1.6
—
—
—
0
0
22
68
3.41
6.13
1.6
1.6
—
—
—
0
0
51
247
2.28
6.11
12.1
7.3
119.92
122.04
g/l
0.36
51
241
11
11
10.32
6.08
3.0
1.3
33.09
68.47
ug/l
1.66
11
11
137
943
1.82
6.06
2.7
2.1
—
—
—
0
0
9
6
15.39
5.94
2.0
1.7
—
—
—
0
0
9
6
15.39
5.94
1.1
1.0
—
—
—
0
0
20
60
3.50
5.83
1.5
1.2
—
—
—
0
0
16
31
5.39
5.79
1.4
1.2
—
—
—
0
0
18
51
3.69
5.69
1.9
2.5
14.55
15.73
%
0.50
13
22
33
135
2.62
5.68
10.8
3.4
—
—
—
0
0
25
88
3.00
5.66
1.9
4.0
41.84
37.74
mg/l
0.15
20
73
145
1036
1.76
5.50
4.6
3.9
30.74
42.88
ng/l
0.82
112
755
46
223
2.25
5.48
2.6
2.7
31.50
33.63
u/l
0.16
40
189
13
21
6.41
5.44
1.4
1.5
—
—
—
0
0
16
43
3.87
5.44
1.4
1.2
1.86
3.94
u/ml
—
7
17
212
1695
1.81
5.38
7.0
4.2
—
—
—
0
0
143
1024
1.74
5.34
2.4
2.0
99.79
94.51
pmol/l
0.65
96
531
157
1156
1.73
5.29
7.5
2.7
—
—
—
0
0
9
10
9.23
4.81
1.2
1.1
1.96
1.76
mmol/l
—
9
10
18
58
3.23
4.72
4.2
1.8
—
—
—
0
0
19
64
3.10
4.64
2.1
4.7
—
—
—
0
0
48
253
2.06
4.63
10.5
4.4
—
—
—
0
0
97
644
1.74
4.60
2.1
1.6
17.83
20.52
nmol/l
1.41
92
544
9
11
8.39
4.59
2.0
1.5
2737.44
1064.18
u/ml
—
9
11
36
171
2.25
4.50
7.9
6.6
24.85
24.06
mmol/l
0.68
36
161
15
45
3.45
4.38
1.9
3.1
—
—
—
0
0
15
38
4.10
4.36
2.3
1.4
—
—
—
0
0
77
486
1.78
4.32
1.7
1.7
978.07
1223.57
nmol/l
1.92
60
364
12
25
4.95
4.23
1.2
1.0
—
—
—
0
0
11
21
5.39
4.18
11.8
2.6
—
—
—
0
0
13
30
4.48
4.18
10.3
2.6
—
—
—
0
0
31
143
2.30
4.15
1.8
1.6
—
—
—
0
0
12
26
4.76
4.10
1.0
1.2
—
—
—
0
0
12
26
4.76
4.10
1.4
1.6
—
—
—
0
0
8
10
8.18
4.08
11.6
4.5
45.13
50.10
%
—
8
10
108
759
1.65
4.07
4.0
2.1
162.62
309.53
u/l
0.71
103
718
21
82
2.68
3.97
7.8
6.2
1.18
1.30
mmol/l
0.27
21
73
8
13
6.28
3.52
2.5
1.0
—
—
—
0
0
6
6
10.16
3.51
1.2
1.0
—
—
—
0
0
27
127
2.23
3.47
1.9
1.2
—
—
—
0
0
12
33
3.74
3.33
4.9
2.4
—
—
—
0
0
100
730
1.55
3.08
3.4
2.9
—
—
—
0
0
6
8
7.62
3.07
2.3
2.5
41816.67
37887.50
ug/l
—
6
8
6
8
7.62
3.07
1.2
1.0
—
—
—
0
0
23
107
2.24
3.05
8.4
5.0
1.77
1.63
%
0.31
23
99
41
240
1.82
2.92
2.2
2.5
16.82
8.54
ug/l
1.14
36
211
108
810
1.51
2.92
4.9
3.2
1402.38
1352.88
ng/l
0.05
103
689
206
1763
1.51
2.89
6.9
4.1
—
—
—
0
0
12
38
3.24
2.88
1.3
1.1
—
—
—
0
0
6
9
6.77
2.88
4.8
1.4
26.67
28.44
umol/l
—
6
9
7
14
5.09
2.74
1.6
2.4
8.50
11.61
%
—
7
14
22
107
2.14
2.64
8.6
5.1
0.95
0.91
%
0.28
22
100
229
2513
0.65
2.61
4.9
5.1
2.60
2.69
mmol/l
0.71
214
2295
269
2468
1.73
2.58
57.9
15.1
31.87
24.60
mg/l
3.05
252
1970
25
130
2.00
2.54
2.7
2.3
—
—
—
0
0
15
63
2.45
2.50
1.3
1.7
289.10
273.41
ug/g
—
10
42
10
32
3.19
2.46
1.6
1.9
—
—
—
0
0
28
155
1.89
2.39
2.1
2.4
—
15.03
—
0
11
147
1206
1.42
2.39
6.3
4.9
0.00
0.00
estimate
-0.00
32
214
5
8
6.33
2.38
1.2
1.5
—
—
—
0
0
30
171
1.84
2.35
3.8
2.5
6.67
5.86
e9/l
0.16
19
136
223
2447
0.68
2.33
4.6
4.5
1.40
1.42
mmol/l
0.35
210
2236
74
535
1.50
2.32
3.9
3.6
—
—
—
0
0
9
29
3.17
2.24
2.1
1.0
—
—
—
0
0
9
29
3.17
2.24
2.1
1.0
—
—
—
0
0
146
1211
1.39
2.16
4.6
3.6
0.00
0.00
estimate
-0.00
33
233
101
787
1.42
2.14
6.0
4.0
—
—
—
0
0
147
1224
1.39
2.11
4.6
3.6
0.00
0.00
estimate
-0.00
31
209
188
1633
1.39
2.08
7.4
3.3
68.21
50.88
u/l
1.18
182
1522
6
15
4.06
2.05
1.0
1.3
—
—
—
0
0
226
2459
0.69
2.04
4.6
4.6
4.49
4.55
mmol/l
0.41
213
2258
14
63
2.28
2.04
7.2
5.7
104.36
105.49
mmol/l
0.60
14
57
14
63
2.28
2.04
7.2
5.7
11.64
11.28
mmol/l
0.16
14
57
8
27
3.01
1.95
1.0
1.3
—
—
—
0
0
5
11
4.60
1.95
1.2
1.2
—
—
—
0
0
9
33
2.78
1.94
4.2
2.1
30.00
33.00
pg
—
9
33
50
346
1.53
1.92
1.7
1.3
—
—
—
0
0
18
93
1.99
1.89
2.7
1.7
—
—
—
0
0
5
12
4.22
1.83
1.0
1.1
132.00
132.25
nmol/l
—
5
12
38
250
1.59
1.82
2.0
2.5
310.10
124.91
ug/g
0.66
30
199
7
23
3.09
1.81
2.9
1.5
—
—
—
0
0
6
18
3.38
1.75
1.0
1.2
—
—
—
0
0
21
121
1.79
1.63
3.0
2.8
0.90
0.69
%
0.50
21
121
71
896
0.73
1.53
3.3
2.9
—
—
—
0
0
41
290
1.48
1.44
4.3
4.6
4.14
56.41
ug/l
1.18
33
244
81
647
1.34
1.43
1.8
1.4
—
—
—
0
0
12
62
1.97
1.29
1.3
1.3
—
3.18
—
0
10
196
1779
1.28
1.28
3.6
3.6
14.81
14.90
pmol/l
0.17
182
1582
12
63
1.94
1.24
1.5
1.2
—
—
—
0
0
40
291
1.43
1.24
1.3
1.3
—
—
—
0
0
8
37
2.19
1.22
3.7
1.2
—
—
—
0
0
8
38
2.13
1.19
1.1
1.3
—
—
—
0
0
5
20
2.52
1.15
2.4
4.8
—
—
—
0
0
51
393
1.36
1.14
1.4
1.3
16.48
35.75
iu/ml
2.08
14
138
11
58
1.93
1.13
2.2
2.7
—
—
—
0
0
69
557
1.31
1.13
1.6
1.8
483.48
440.28
pmol/l
0.46
62
465
7
31
2.29
1.11
1.9
1.2
—
—
—
0
0
5
21
2.40
1.09
1.2
1.0
—
—
—
0
0
223
2369
0.79
1.07
4.4
4.1
1.31
1.28
mmol/l
0.22
212
2157
42
318
1.37
1.05
1.3
1.3
—
—
—
0
0
7
35
2.02
1.00
1.6
1.9
87.87
89.97
%
—
7
35
0
30
0.00
0.98
0.0
2.6
—
—
—
0
0
7
37
1.91
0.94
2.4
8.5
6.47
7.01
mmol/l
—
7
30
6
27
2.25
0.94
2.2
3.1
—
—
—
0
0
220
2328
0.81
0.92
5.5
6.0
40.89
40.19
mmol/mol
0.48
206
2152
28
203
1.42
0.91
4.1
3.6
—
—
—
0
0
6
29
2.09
0.90
1.0
1.3
—
—
—
0
0
8
43
1.88
0.88
1.0
1.5
—
—
—
0
0
8
45
1.80
0.85
1.1
2.6
—
—
—
0
0
13
81
1.63
0.82
1.7
1.6
—
—
—
0
0
18
122
1.51
0.82
2.7
2.5
—
—
—
0
0
81
698
1.22
0.77
4.2
3.2
—
—
—
0
0
7
43
1.64
0.67
2.1
1.9
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
245.00
—
0
13
75
660
1.18
0.58
4.4
3.8
0.00
0.00
estimate
-0.00
31
210
9
132
0.67
0.53
1.4
1.4
—
—
—
0
0
17
126
1.37
0.53
4.8
3.9
—
—
—
0
0
61
540
1.16
0.45
4.3
3.9
1.02
1.02
kg/l
—
8
75
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
264
2577
1.17
0.41
39.1
14.2
—
—
—
0
0
235
2419
0.88
0.40
5.2
4.8
5.99
6.03
mmol/l
0.13
226
2204
0
18
0.00
0.40
0.0
1.9
—
—
—
0
0
8
61
1.32
0.40
1.1
1.4
—
300.06
—
0
27
0
19
0.00
0.39
0.0
3.7
—
25.00
—
0
6
43
375
1.17
0.38
1.3
1.3
3.39
14.03
u/ml
1.53
17
155
13
99
1.33
0.36
4.8
4.4
—
—
—
0
0
72
657
1.13
0.35
1.8
1.7
1.31
1.36
mmol/l
0.23
61
541
269
2739
0.86
0.35
71.1
22.1
37.97
40.41
%
10.63
255
2563
19
155
1.24
0.33
2.5
2.6
—
—
—
0
0
57
518
1.12
0.30
1.2
1.2
0.94
1.30
u/ml
0.37
19
142
12
94
1.29
0.28
2.3
3.4
0.25
0.21
g/l
—
6
33
228
2223
1.10
0.28
4.5
4.4
1.85
1.97
mu/l
0.96
212
1998
21
178
1.19
0.27
1.2
1.1
—
—
—
0
0
5
41
1.22
0.22
4.8
3.3
4.06
4.02
mmol/l
—
5
41
5
41
1.22
0.22
4.8
3.3
—
—
—
0
0
5
41
1.22
0.22
4.8
3.3
110.20
105.17
mmol/l
—
5
41
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
6.5
—
—
—
0
0
0
13
0.00
0.21
0.0
9.4
—
0.66
—
0
13
0
14
0.00
0.20
0.0
11.9
—
849.79
—
0
14
0
14
0.00
0.20
0.0
15.4
—
1663.71
—
0
14
6
51
1.18
0.19
2.0
1.5
—
—
—
0
0
24
214
1.13
0.18
3.3
3.2
—
—
—
0
0
5
66
0.75
0.17
9.8
4.3
31.00
28.74
mg/l
—
5
43
6
76
0.79
0.16
1.2
1.1
—
—
—
0
0
15
170
0.88
0.14
1.2
1.4
—
—
—
0
0
5
44
1.14
0.10
1.2
1.1
—
—
—
0
0
80
777
1.04
0.08
4.1
3.2
1358.57
294.46
mg/l
0.61
56
524
5
63
0.79
0.08
1.8
1.4
—
—
—
0
0
121
1186
1.03
0.08
4.7
5.1
1.92
2.59
ug/l
1.19
107
1066
6
71
0.84
0.07
2.0
1.4
—
—
—
0
0
6
70
0.85
0.07
2.2
1.4
—
—
—
0
0
6
70
0.85
0.07
2.0
1.4
—
—
—
0
0
8
77
1.04
0.07
7.4
4.7
—
—
—
0
0
7
81
0.86
0.07
1.6
1.7
—
—
—
0
0
83
811
1.03
0.06
4.3
3.1
6.74
8.02
mmol/l
2.24
74
673
83
812
1.03
0.06
5.0
3.8
18.52
7.48
mg/mmol
1.11
60
527
19
200
0.95
0.04
1.3
1.4
—
—
—
0
0
11
103
1.07
0.02
1.1
1.2
—
—
—
0
0
24
247
0.97
0.01
2.2
1.5
—
—
—
0
0
13
133
0.98
0.00
1.0
1.2
—
—
—
0
0
70
696
1.01
0.00
3.0
3.1
0.63
0.80
ug/l
1.60
53
467
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
62
0.97
-0.00
1.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
1.19
—
0
6
0
6
0.00
-0.00
0.0
1.8
—
3090.00
—
0
6
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
7.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.6
—
24.07
—
0
7
8
83
0.96
-0.00
13.3
12.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
20.20
—
0
5
6
69
0.87
-0.00
2.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint AB1_ASPERGILLOSIS and mortality.

Females

Parameter HR [95% CI] p-value
AB1_ASPERGILLOSIS 4.089 [3.03, 5.52] < 0.001
Birth year 0.994 [0.99, 1.0] 0.199

During the follow-up period (1.1.1998 — 31.12.2019), 157 out of 432 females with AB1_ASPERGILLOSIS died.

Males

Parameter HR [95% CI] p-value
AB1_ASPERGILLOSIS 5.317 [4.05, 6.99] < 0.001
Birth year 0.988 [0.98, 1.0] 0.016

During the follow-up period (1.1.1998 — 31.12.2019), 377 out of 732 males with AB1_ASPERGILLOSIS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_ASPERGILLOSIS.

N-year risk Females Males
1 0.413% 0.945%
5 2.448% 6.264%
10 6.095% 14.861%
15 11.683% 27.194%
20 19.595% 41.719%

Relationships between endpoints

Index endpoint: AB1_ASPERGILLOSIS – Aspergillosis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data